/KIDS

OrthoPediatrics Corp

KIDS

$22.06USD↑+2.32%+0.50 today

MARKET CAP

576.0M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$21 – $22

52W RANGE

$14

$27

AI Summary

Stalk

Sell NowHigh

KIDS remains in a Stage 4 decline with confirmed lower highs and lows and price below all key moving averages; there are no signs of selling exhaustion, volume and volatility support further downside, and both medium- and short-term signals align with a bearish continuation, favoring selling on breakdown into the next support area.

↑Q2 2026 revenue grew 15% YoY to $70.5M, led by trauma and deformity products.
↑Launched 3P Pediatric Plating Platform Hip System; management expects revenue to build further.
↓Net losses persist; weak profitability metrics raise questions on long-term returns.

Full analysis →

Buying

5

institutions

Selling

4

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.27 M	24.35 M	+98.67 K	+30.7%	0.00%
MM Millennium Management LLC Q2 2026	SELL	816.83 K	15.63 M	+-420.07 K	-20.4%	0.01%
CA Citadel Advisors LLC Q2 2026	BUY	334.65 K	6.40 M	+149.26 K	+117.6%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUYNEW	78.29 K	1.50 M	+78.29 K	+0.0%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	BUY	25.00 K	478.25 K	+5.16 K	+51.9%	0.02%
PA Point72 Asset Management, L.P. Q2 2026	SELL	23.13 K	442.40 K	+-12.81 K	-22.4%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	7.97 K	160.10 K	+462.00	+40.2%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-19.59 K	-100.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-15.01 K	-100.0%	0.00%